tiprankstipranks
Trending News
More News >
Faron Pharmaceuticals Oy (GB:FARN)
LSE:FARN
UK Market

Faron Pharmaceuticals Oy (FARN) Financial Statements

Compare
61 Followers

Faron Pharmaceuticals Oy Financial Overview

Faron Pharmaceuticals Oy's market cap is currently £70.50M. The company's EPS TTM is p-0.0895918617; its P/E ratio is -2.36; Faron Pharmaceuticals Oy is scheduled to report earnings on March 4, 2026, and the estimated EPS forecast is p-0.10. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Dec 21Dec 20Dec 19Dec 18
Income Statement
Total Revenue
Gross Profit$ 803.00K----
Operating Income$ -27.43M$ -21.11M$ -16.65M$ -13.10M$ -19.65M
EBITDA$ -27.05M$ -20.96M$ -16.79M$ -13.10M$ -19.86M
Net Income$ -28.73M$ -21.19M$ -16.94M$ -13.26M$ -20.09M
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 11.27M$ 13.18M$ 8.37M$ 10.21M$ 8.00M
Total Debt$ 13.27M$ 3.55M$ 3.23M$ 2.82M$ 2.13M
Net Debt$ 6.28M$ -3.31M$ -883.00K$ -4.24M$ -1.94M
Total Liabilities$ 22.75M$ 10.26M$ 10.22M$ 8.60M$ 7.63M
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ -23.38M$ -22.22M--$ -20.82M
Operating Cash Flow$ -22.99M$ -22.22M$ -17.48M$ -11.52M$ -20.52M
Investing Cash Flow
Financing Cash Flow
Currency in USD

Faron Pharmaceuticals Oy Earnings and Revenue History

Faron Pharmaceuticals Oy Debt to Assets

Faron Pharmaceuticals Oy Cash Flow

Faron Pharmaceuticals Oy Forecast EPS vs Actual EPS